Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Extended Stay America Inc (STAY)Hedge Funds Are Snapping Up

Page 1 of 2

Is Extended Stay America Inc (NYSE:STAY) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy League graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage of news stories covering failed hedge fund investments (for some reason media paid a ton of attention to Ackman’s gigantic JC Penney and Valeant failures) and it is a fact that hedge funds’ picks don’t beat the market 100% of the time, but their consensus picks have historically done very well and have outperformed the market after adjusting for risk.

Extended Stay America Inc (NYSE:STAY) investors should pay attention to an increase in support from the world’s most elite money managers recently. STAY was in 16 hedge funds’ portfolios at the end of the third quarter of 2015. There were 13 hedge funds in our database with STAY holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as J2 Global Inc (NASDAQ:JCOM), PAREXEL International Corporation (NASDAQ:PRXL), and Neurocrine Biosciences, Inc. (NASDAQ:NBIX) to gather more data points.

Follow Extended Stay America Inc. (NYSE:STAY)
Trade (NYSE:STAY) Now!

To most shareholders, hedge funds are viewed as worthless, outdated investment vehicles of years past. While there are more than 8000 funds with their doors open today, Our researchers hone in on the moguls of this group, about 700 funds. These money managers administer most of all hedge funds’ total capital, and by following their first-class investments, Insider Monkey has come up with several investment strategies that have historically outrun Mr. Market. Insider Monkey’s small-cap hedge fund strategy outstripped the S&P 500 index by 12 percentage points a year for a decade in their back tests.

With all of this in mind, we’re going to take a peek at the recent action regarding Extended Stay America Inc (NYSE:STAY).

What have hedge funds been doing with Extended Stay America Inc (NYSE:STAY)?

At the end of the third quarter, a total of 16 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 23% from the second quarter. With hedgies’ capital changing hands, there exists a select group of noteworthy hedge fund managers who were boosting their holdings significantly (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Centerbridge Partners, managed by Mark T. Gallogly, holds the number one position in Extended Stay America Inc (NYSE:STAY). Centerbridge Partners has an $799.8 million position in the stock, comprising 46.5% of its 13F portfolio. The second largest stake is held by Paulson & Co, managed by John Paulson, which holds an $799.8 million position; the fund has 4.2% of its 13F portfolio invested in the stock. Remaining professional money managers that are bullish encompass Jeffrey Furber’s AEW Capital Management, and Israel Englander’s Millennium Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!